OncLive® On Air
OncLive® On Air
Add to My Podcasts
Episodes
About
Reviews
Promote
S17 Ep38: FDA Approval Insights: Decitabine/Cedazuridine Plus Venetoclax for AML: With Courtney D. DiNardo, MD, MSCE
10 minutes
Posted Jun 29, 2026 at 12:33 pm.
0:00
10:04
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Courtney D. DiNardo, MD, MSCE, discusses the FDA approval of decitabine and cedazuridine plus venetoclax for acute myeloid leukemia.
Previous
S17 Ep37: Live Tumor Board: Translating Biomarker Insights and Therapeutic Advances Into Endometrial Cancer Practice
Next
S17 Ep39: Sequencing and Emerging Targets Revamp the Platinum-Resistant Ovarian Cancer Treatment Paradigm: With David O’Malley, MD
← See all 500 episodes of OncLive® On Air